BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27712939)

  • 1. Design, synthesis, and activity evaluation of selective inhibitors of anti-apoptotic Bcl-2 proteins: The effects on the selectivity of the P1 pockets in the active sites.
    Wang M; Tian W; Wang C; Lu S; Yang C; Wang J; Song Y; Zhou Y; Zhu J; Li Z; Zheng C
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5207-5211. PubMed ID: 27712939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors.
    Wang Z; Xu W; Song T; Guo Z; Liu L; Fan Y; Wang A; Zhang Z
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27911011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
    Xu G; Liu T; Zhou Y; Yang X; Fang H
    Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of 3-phenyl-N-(2-(3-phenylureido)ethyl)-thiophene-2-sulfonamide compounds as inhibitors of antiapoptotic Bcl-2 family proteins.
    Yang C; Chen S; Zhou M; Li Y; Li Y; Zhang Z; Liu Z; Ba Q; Li J; Wang H; Yan X; Ma D; Wang R
    ChemMedChem; 2014 Jul; 9(7):1436-52. PubMed ID: 24782462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.
    Zheng CH; Yang H; Zhang M; Lu SH; Shi D; Wang J; Chen XH; Ren XH; Liu J; Lv JG; Zhu J; Zhou YJ
    Bioorg Med Chem Lett; 2012 Jan; 22(1):39-44. PubMed ID: 22172701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
    Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
    ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors.
    Liu T; Wan Y; Liu R; Ma L; Li M; Fang H
    Bioorg Med Chem; 2017 Mar; 25(6):1939-1948. PubMed ID: 28233676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1) derivatives as pan-Bcl-2-inhibitors of Bcl-2, Bcl-xL and Mcl-1.
    Song T; Li X; Chang X; Liang X; Zhao Y; Wu G; Xie S; Su P; Wu Z; Feng Y; Zhang Z
    Bioorg Med Chem; 2013 Jan; 21(1):11-20. PubMed ID: 23206987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
    Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
    J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors.
    Liang X; Li X; Zhao Z; Nie Y; Yao Z; Ren W; Yang X; Hou X; Fang H
    Bioorg Chem; 2022 Apr; 121():105643. PubMed ID: 35150958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
    Liu R; Liu L; Liu T; Yang X; Wan Y; Fang H
    Bioorg Med Chem; 2018 Sep; 26(17):4907-4915. PubMed ID: 30170927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design, synthesis, and evaluation of Bcl-2/Mcl-1 dual inhibitors.
    Zhu J; Wang Z; Guo Z; Zhang X; Song T; Guo Y; Ji T; Zhang Z
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000005. PubMed ID: 32175625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2/Mcl-1 dual inhibitors.
    Chen C; Nie Y; Xu G; Yang X; Fang H; Hou X
    Bioorg Med Chem; 2019 Jul; 27(13):2771-2783. PubMed ID: 31079964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
    Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
    J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors.
    Fu H; Hou X; Wang L; Dun Y; Yang X; Fang H
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5265-9. PubMed ID: 26421995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and pharmacological evaluation of new acyl sulfonamides as potent and selective Bcl-2 inhibitors.
    Liu X; Zhang Y; Huang W; Tan W; Zhang A
    Bioorg Med Chem; 2018 Jan; 26(2):443-454. PubMed ID: 29229225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins.
    Tang G; Yang CY; Nikolovska-Coleska Z; Guo J; Qiu S; Wang R; Gao W; Wang G; Stuckey J; Krajewski K; Jiang S; Roller PP; Wang S
    J Med Chem; 2007 Apr; 50(8):1723-6. PubMed ID: 17378545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins.
    Tang G; Ding K; Nikolovska-Coleska Z; Yang CY; Qiu S; Shangary S; Wang R; Guo J; Gao W; Meagher J; Stuckey J; Krajewski K; Jiang S; Roller PP; Wang S
    J Med Chem; 2007 Jul; 50(14):3163-6. PubMed ID: 17552510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
    Wang G; Nikolovska-Coleska Z; Yang CY; Wang R; Tang G; Guo J; Shangary S; Qiu S; Gao W; Yang D; Meagher J; Stuckey J; Krajewski K; Jiang S; Roller PP; Abaan HO; Tomita Y; Wang S
    J Med Chem; 2006 Oct; 49(21):6139-42. PubMed ID: 17034116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 family proteins as targets for anticancer drug design.
    Huang Z
    Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.